RECRUITING

Mindfulness to Enhance Cognitive Health in Latinx Older Adults

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective of the proposed research is to investigate the promise and underlying mechanisms of mindfulness training as a preventative lifestyle intervention to enhance cognitive health in Latinx older adults, thereby mitigating risk of Alzheimer's Disease (AD) in a population that may be particularly vulnerable.

Official Title

Mindfulness to Enhance Cognitive Health in Latinx Older Adults

Quick Facts

Study Start:2024-12-10
Study Completion:2026-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07040904

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Hispanic/Latinx
  2. * Age 65 and older
  3. * Male, female, or non-binary
  4. * Community living
  5. * Medically stable and willing to undergo the study procedures
  6. * No extensive mindfulness training experience
  1. * Clinically unstable psychiatric disorder that requires immediate treatment (e.g., ECT)
  2. * Medical conditions suggesting significantly shortened lifespan (e.g., metastatic cancer) or prohibiting safe participation in the interventions/assessments (e.g., Parkinson's disease, musculoskeletal conditions)
  3. * Sensory impairment (hearing, vision) preventing participation
  4. * Current alcohol or substance abuse
  5. * Current/concurrent cognitive training known to affect neuroplasticity (e.g., brain-training programs), or other interventions expected to affect neuroplasticity significantly (e.g., psychedelics, cholinesterase inhibitors, high-dose sedatives).

Contacts and Locations

Study Contact

Todd S Braver, Ph.D.
CONTACT
800-438-0445
tbraver@wustl.edu
Diana Parra Perez, Ph.D.
CONTACT
parrad@wustl.edu

Study Locations (Sites)

Washington University
Saint Louis, Missouri, 63130
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-10
Study Completion Date2026-07-31

Study Record Updates

Study Start Date2024-12-10
Study Completion Date2026-07-31

Terms related to this study

Keywords Provided by Researchers

  • AD Biomarkers
  • Alzheimer's Disease
  • Alzheimer's disease and related dementias
  • cognitive behavioral intervention
  • Mindfulness
  • Mindfulness Training

Additional Relevant MeSH Terms

  • Mindfulness
  • Alzheimer's Disease Related Dementia